BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 9056156)

  • 1. New non-ionic contrast: effects on the cardiovascular system.
    Pagny JY; Gaux JC
    Eur J Radiol; 1996 Nov; 23 Suppl 1():S2-5. PubMed ID: 9056156
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Safety profile of new non-ionic contrast media: renal tolerance.
    Stacul F; Thomsen HS
    Eur J Radiol; 1996 Nov; 23 Suppl 1():S6-9. PubMed ID: 9056157
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Hemodynamic effects of non-ionic iomeprol 350 and ionic diatrizoate 370 during levocardiography and coronary angiography--double-blind randomized comparison of 2 contrast media].
    Lins M; Röhling D; Zahorsky R; Höfig M; Herrmann G; Simon R
    Z Kardiol; 1994 Sep; 83(9):626-33. PubMed ID: 7801664
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hemodynamic effects of contrast media during coronary angiography: a comparison of three nonionic agents to Hypaque-76.
    Piao ZE; Murdock DK; Hwang MH; Raymond RM; Scanlon PJ
    Cathet Cardiovasc Diagn; 1988; 14(1):53-8. PubMed ID: 3349517
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical utility and safety profile of iomeprol.
    Rosati G
    Eur J Radiol; 1994 May; 18 Suppl 1():S120-4. PubMed ID: 8020514
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of hemodynamic and Doppler echocardiographic effects of a new low osmolar nonionic and a standard ionic contrast agent after left ventriculography.
    Werner GS; Schmidt T; Scholz KH; Figulla HR; Kreuzer H
    Cathet Cardiovasc Diagn; 1994 Sep; 33(1):11-9. PubMed ID: 8001095
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Iomeprol: a review of its use as a contrast medium.
    Dooley M; Jarvis B
    Drugs; 2000 May; 59(5):1169-86. PubMed ID: 10852647
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Variable effects of radiological contrast media on thrombus growth in a rabbit jugular vein thrombosis model.
    Levi M; Biemond BJ; Sturk A; Hoek J; ten Cate JW
    Thromb Haemost; 1991 Aug; 66(2):218-21. PubMed ID: 1771615
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical superiority of a new nonionic contrast agent (iopamidol) for cardiac angiography.
    Gertz EW; Wisneski JA; Chiu D; Akin JR; Hu C
    J Am Coll Cardiol; 1985 Feb; 5(2 Pt 1):250-8. PubMed ID: 3881496
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Coronary angiography during acute myocardial infarction in dogs: comparison of the hemodynamic effects of ionic and nonionic contrast media.
    Piao ZE; Murdock DK; Hwang MH; Gries W; Raymond RM; Scanlon PJ
    J Lab Clin Med; 1988 Sep; 112(3):319-23. PubMed ID: 3411193
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical pharmacology of iomeprol.
    Rosati G
    Eur J Radiol; 1994 May; 18 Suppl 1():S51-60. PubMed ID: 8020519
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Early hemodynamic cardiovascular reactions to nonionic low-osmolar contrast media in coronary angiography].
    Wink K
    Rontgenblatter; 1988 Sep; 41(9):384-8. PubMed ID: 3175478
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A randomized trial comparing the impact of a nonionic (Iomeprol) versus an ionic (Ioxaglate) low osmolar contrast medium on abrupt vessel closure and ischemic complications after coronary angioplasty.
    Schräder R; Esch I; Ensslen R; Fach WA; Merle H; Scherer D; Sievert H; Spies HF; Zeplin HE
    J Am Coll Cardiol; 1999 Feb; 33(2):395-402. PubMed ID: 9973019
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacodynamic effects of iomeprol for injection in experimental animals.
    Cipolla P; Tirone P; Luzzani F; de Haën C
    Eur J Radiol; 1994 May; 18 Suppl 1():S32-42. PubMed ID: 8020517
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytotoxic effects of ionic high-osmolar, nonionic monomeric, and nonionic iso-osmolar dimeric iodinated contrast media on renal tubular cells in vitro.
    Heinrich MC; Kuhlmann MK; Grgic A; Heckmann M; Kramann B; Uder M
    Radiology; 2005 Jun; 235(3):843-9. PubMed ID: 15845795
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical usefulness of iomeprol 400 mgl/ml in cardioangiography evaluation of patient discomfort and hemodynamic and ECG effects.
    Himi K; Takemoto A; Himi S; Tanaka Y; Hirayama T; Katayama Y; Tomaru T
    Acad Radiol; 1998 Apr; 5 Suppl 1():S54-7. PubMed ID: 9561044
    [No Abstract]   [Full Text] [Related]  

  • 17. Iomeprol and iopamidol in cardiac angiography: a randomised, double-blind, parallel-group comparison.
    Fattori R; Piva R; Schicchi F; Pancrazi A; Gabrielli G; Marzocchi A; Piovaccari G; Blandini A; Magnani B
    Eur J Radiol; 1994 May; 18 Suppl 1():S61-6. PubMed ID: 8020520
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preclinical safety assessment of iomeprol for injection as contrast medium for myelography.
    La Noce A; Bertani F; Lorusso V; Luzzani F; Tirone P; de Haën C
    Eur J Radiol; 1994 May; 18 Suppl 1():S43-50. PubMed ID: 8020518
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of ionic and nonionic contrast media on cardiohemodynamics and quality of radiographic image during canine angiography.
    Nakamura H; Kurata M; Haruta K; Takeda K
    J Vet Med Sci; 1994 Feb; 56(1):91-6. PubMed ID: 8204767
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Early hemodynamic reactions of an ionic low osmolar and a nonionic contrast medium].
    Wink K; Heinrich R
    Z Kardiol; 1984 Oct; 73(10):628-33. PubMed ID: 6516515
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.